Tumor necrosis could reflect advanced disease status in patients with diffuse large B cell lymphoma treated with R-CHOP therapy

Tumor necrosis at FDG-PET is an independent predictor of outcome in diffuse large B-cell lymphoma

(2016) Hugo J.A. Adams et al.   EUROPEAN JOURNAL OF RADIOLOGY

Clinical significance of post-treatment 18F-fluorodeoxyglucose uptake in cervical lymph nodes in patients with diffuse large B-cell lymphoma

(2016) Young-Sil An et al.   EUROPEAN RADIOLOGY

Prognostic value of tumor necrosis at CT in diffuse large B-cell lymphoma

(2015) Hugo J.A. Adams et al.   EUROPEAN JOURNAL OF RADIOLOGY

Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era

(2013) Irit Avivi et al.   AMERICAN JOURNAL OF HEMATOLOGY

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

(2013) Z. Zhou et al.   BLOOD

The Histological and Biological Spectrum of Diffuse Large B-Cell Lymphoma in the World Health Organization Classification

(2012) Madhu P. Menon et al.   CANCER JOURNAL

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

(2011) E. Campo et al.   BLOOD

Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+B-Cell Lymphoma in the Rituximab Era

(2010) Marita Ziepert et al.   JOURNAL OF CLINICAL ONCOLOGY

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0

(2009) Ronald Boellaard et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients

(2009) M. Weiler-Sagie et al.   JOURNAL OF NUCLEAR MEDICINE